Drug factory · FDA FEI 3002806998

Finorga

AVENUE DU LAC, Mourenx, France

France: 1

Problems found, fixed voluntarily at FDA's last inspection, Nov 24, 2023.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

4 drug inspections on record since 2013: 2 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
EncorafenibMakes the active ingredient Array BioPharma Inc. 70255-050

FDA inspection history

EndedResultProgramProblems noted
Nov 24, 2023Problems found, fixed voluntarilyDrug Quality Assurance—
Sep 20, 2019No problems foundDrug Quality Assurance—
Sep 23, 2016No problems foundDrug Quality Assurance—
Dec 13, 2013Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: analysis; api manufacture.